Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Diluted EPS of $6.74 per share (loss) for fiscal year 2025.
INTEGRA LIFESCIENCES HOLDINGS CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.74 | -7388.9% |
| 2024 | -$0.09 | -110.7% |
| 2023 | $0.84 | -61.1% |
| 2022 | $2.16 | +9.1% |
| 2021 | $1.98 | +26.1% |
| 2020 | $1.57 | +170.7% |
| 2019 | $0.58 | -19.4% |
| 2018 | $0.72 | -12.2% |
| 2017 | $0.82 | -12.8% |
| 2016 | $0.94 | +1980.0% |
| 2015 | -$0.05 | -109.6% |
| 2014 | $0.52 | +170.3% |
| 2013 | -$0.74 | -151.4% |
| 2012 | $1.44 | +51.6% |
| 2011 | $0.95 | -56.2% |
| 2010 | $2.17 | +24.7% |
| 2009 | $1.74 | +81.3% |
| 2008 | $0.96 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.07 | +50.0% | +98.9% |
| June 30, 2025 | -$6.31 | -3843.7% | -1812.1% |
| March 31, 2025 | -$0.33 | -725.0% | -135.7% |
| September 30, 2024 | -$0.14 | -158.3% | +12.5% |
| June 30, 2024 | -$0.16 | -420.0% | -300.0% |
| March 31, 2024 | -$0.04 | -113.8% | -116.7% |
| September 30, 2023 | $0.24 | -60.0% | +380.0% |
| June 30, 2023 | $0.05 | -90.7% | -82.8% |
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -7388.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, INTEGRA LIFESCIENCES HOLDINGS CORP’s diluted eps has declined by 802.1% (from $0.96 per share to $6.74 per share (loss)).
- The most recent figure is from INTEGRA LIFESCIENCES HOLDINGS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: